SWShlomo Walfisch

Shlomo Walfisch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shlomo Walfisch has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • DIAMOND SHAPED OPTICAL FIBER DELIVERY SYSTEM

    by Haim Mnitentag, Alexander Gersten, Shlomo Walfisch

    Optical fibers are generally used with a flat cut end. The adaptation of a coaxial exit of a refrigerated gas near the distal tip of the optical fiber cools the tissue where the laser beam is applied and reduces the injury of thermal effects on biological tissue. We have changed the flat end geometry of the fiber's end to a pyramidal end shape (named: Diamond tip). In this project we have evaluated the new shape of the fiber's end using laboratory tests and in real conditions. We have examined the emission pattern in the air and in water as well as its performance in surgery. With the new shape better results were obtained: higher power density, more utilizations of the same fiber (after sterilization) resulting in economical savings. The diamond tip is characterized by greater mechanical resistance then conical tip delivery systems. The greater resistance of the Diamond tip prevents optical fiber breakage during surgery. The delivered system can be reshaped by a trained hospital physician and reused. Our experience shows that delivery systems intended by the producer to one use only can be converted, by reshaping their tips, to highly performing delivery systems, which can be reused many times. In addition less power was needed, with less tissue penetration. The thermal effect was minimized and higher mechanical resistance was achieved, which allowed reusing the fiber more than six times. The special structure of the faces of the optical fiber diamond tip eased its sliding. The Diamond tip is superior to other fiber end tips by having minimal thermal effects, higher mechanical resistance and by being reused many times.

  • The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour

    by S. Machlenkin, I. Pinsk, H. Tulchinsky, Y. Ziv, J. Sayfan, D. Duek, M. Rabau, S. Walfisch

    Aim The study aimed to characterize the pathological and clinical response of rectal gastrointestinal stromal tumours (GISTs) to neoadjuvant Imatinib. Method The medical records of patients with rectal GISTs who were diagnosed and treated in five medical centres in Israel between January 2002 and January 2009 were retrospectively examined. Twelve patients who fulfilled the inclusion criteria of nonmetastatic rectal GIST for which preoperative neoadjuvant treatment with Imatinib was considered were suitable for enrollment. Results Of the 12 patients, nine received neoadjuvant treatment with Imatinib. The three patients who had immediate surgery were excluded. There were five men and four women with a median age of 63 years and a median follow up of 32 months. All tumours were located in the lower two-thirds of the rectum. One patient had a complete clinical response, six had a partial response and two had stable disease. Seven patients subsequently underwent surgery; six had an R0 resection and one had an R1 resection. Three patients had recurrence. There was no disease-related mortality. The reduction in both tumour size and mitotic activity during preoperative Imatinib therapy was significant. Conclusion Preoperative Imatinib therapy can shrink large rectal GISTs, improving the chances of successful radical surgery and decreasing the risk of considerable morbidity.


  • The Role of Tomato Lycopene in Cancer Prevention

    by Joseph Levy, Shlomo Walfisch, Andrea Atzmon, Keren Hirsch, Marina Khanin, Karin Linnewiel, Yael Morag, Hagar Salman, Anna Veprik, Michael Danilenko, et al.